Use in Pregnancy: Pre-clinical data for oxytocin reveal no special hazard based on conventional studies of single dose acute toxicity, genotoxicity, and mutagenicity. No standard teratogenicity and reproductive performance studies with oxytocin are available. Based on the wide experience with this drug and its chemical structure and pharmacological properties, it is not expected to present a risk of fetal abnormalities when used as indicated.
Use in Lactation: Oxytocin may be found in small quantities in mother's breast milk. However, oxytocin is not expected to cause harmful effects in the newborn because it passes into the alimentary tract where it undergoes rapid inactivation.